Form 4: Rocket Pharmaceuticals Director Wong Acquires Stock Options

Director Roderick Wong acquired stock options for Rocket Pharmaceuticals shares on June 13, 2024.

Summary

• On June 13, 2024, Rocket Pharmaceuticals Director Roderick Wong acquired stock options to purchase 23,944 shares of common stock at an exercise price of $22.86.
• Additionally, Wong acquired options to purchase 3,325 shares of common stock at an exercise price of $22.86, issued in lieu of $50,000 in director retainer fees.
• Both options vest fully on June 13, 2025, and expire on June 13, 2034.
• Following the transaction, Wong directly owns options for a total of 27,269 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of stock options, which can be seen as a positive sign of confidence, but it's not overwhelmingly positive.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of stock options by a director can positively influence shareholder sentiment, as it aligns the director's interests with those of the shareholders.

Key Dates